HUMAN COLONIC SULFOMUCIN IDENTIFIED BY A SPECIFIC MONOCLONAL-ANTIBODY

被引:0
|
作者
IRIMURA, T
WYNN, DM
HAGER, LG
CLEARY, KR
OTA, DM
机构
[1] UNIV TEXAS, MD ANDERSON CANC CTR, DEPT TUMOR BIOL, HOUSTON, TX 77030 USA
[2] UNIV TEXAS, MD ANDERSON CANC CTR, DEPT PATHOL, HOUSTON, TX 77030 USA
[3] UNIV TEXAS, MD ANDERSON CANC CTR, DEPT GEN SURG, HOUSTON, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Since the 1960s, the loss of sulfomucin from colonic epithelium has been considered to be an indicator of an early stage of carcinogenesis; yet, the biochemical basis for this phenomenon has never been elucidated. We recently prepared a monoclonal antibody (mAb) 91.9H that immunoprecipitates the normal colonic mucins metabolically incorporating [S-35]-sulfate. This mouse IgG1 antibody did not cross-react with colon carcinoma mucins that lack sulfate groups. Using normal colonic epithelia unlabeled or radiolabeled with [S-35]sulfate and [H-3]glucosamine, we purified a high molecular weight glycoprotein that reacts with mAb 91.9H. This was achieved by a combination of DEAE-cellulose anion-exchange chromatography, consecutive treatments with chondroitinase ABC plus heparitinase and with sodium dodecyl sulfate plus 2-mercaptoethanol, and gel filtration on Sepharose CL-2B in the presence of 8 M urea. Antibody reactivity was found in acidic but not neutral high molecular weight glycoproteins. After Sepharose CL-2B fractionation, the mAb 91.9H-reactive fractions consisted of a component with an approximate molecular weight of 500,000-900,000. A purified sulfomucin contained protein, neutral sugar. amino sugar, sialic acid, and sulfate in an approximate ratio of 2.5:1.0:1.1:0.4:0.5. The polypeptide portion was rich in hydrophilic amino acids, particularly threonine. Binding of mAb 91.9H in solid-phase assays was inhibited to 50% by purified normal colon acidic mucin at doses of 5-50-mu-g/ml, depending on different preparations. Various glycosaminoglycans or sulfatides did not show inhibitory activity. Sulfomucin reactivity with mAb 91.9H, as determined by solid-phase-binding inhibition and by dot blot assays, was significantly reduced by chemical desulfation of sulfomucins with anhydrous hydrochloric acid, suggesting that sulfate groups served as a portion of the immunochemical determinant for this antibody. Sulfate residues were apparently linked to alkaline-sensitive carbohydrate chains, but alkaline-released carbohydrate chains did not react with mAb 91.911. Immunohistochemical examinations showed that mAb 91.9H bound normal colonic epithelial cells, which also stained with high-iron diamine, more strongly than it bound colon carcinoma cells.
引用
收藏
页码:5728 / 5735
页数:8
相关论文
共 50 条
  • [21] IMMUNOTHERAPY WITH A HUMAN MONOCLONAL-ANTIBODY
    KLATT, HJ
    PERFUSION, 1991, 4 (10): : 366 - 366
  • [22] A HUMAN MONOCLONAL-ANTIBODY TO INSULIN
    LIVNEH, A
    AVRAHAM, H
    ELIAS, D
    SACK, J
    COHEN, IR
    ESHHAR, Z
    DIABETES, 1986, 35 (01) : 68 - 73
  • [23] MONOCLONAL-ANTIBODY TO HUMAN CYTOTROPHOBLAST
    LOKE, YW
    DAY, S
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1984, 5 (03): : 106 - 108
  • [24] A HUMAN MONOCLONAL-ANTIBODY TO RHG
    FOUNG, SKH
    BLUNT, J
    PERKINS, S
    WINN, L
    GRUMET, FC
    VOX SANGUINIS, 1986, 50 (03) : 160 - 163
  • [25] MONOCLONAL-ANTIBODY TO HUMAN THYROTROPIN
    RIDGWAY, EC
    ARDISSON, LJ
    MESKELL, MJ
    MUDGETTHUNTER, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (01): : 44 - 48
  • [26] A MONOCLONAL-ANTIBODY TO HUMAN FILAGGRIN
    KUBILUS, J
    BADEN, HP
    CLINICAL RESEARCH, 1984, 32 (03): : A713 - A713
  • [27] A LIVER-STAGE SPECIFIC ANTIGEN OF P-BERGHEI IDENTIFIED BY A MONOCLONAL-ANTIBODY
    WINGER, L
    SUHRBIER, A
    ODOWD, CA
    HODIVALA, KJ
    SINDEN, RE
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1990, 68 : 172 - 177
  • [28] A SPECIFIC MONOCLONAL-ANTIBODY OF TUMORAL TISSUES
    COMBARET, V
    PORTOUKALIAN, J
    DORE, JF
    BULLETIN DU CANCER, 1986, 73 (04) : 396 - 396
  • [29] A MONOCLONAL-ANTIBODY SPECIFIC FOR A DYNORPHIN PRECURSOR
    BARRETT, RW
    GOLDSTEIN, A
    NEUROPEPTIDES, 1985, 6 (02) : 113 - 120
  • [30] MONOCLONAL-ANTIBODY TO THE PROSTATE SPECIFIC ANTIGEN
    DONN, F
    BRUNS, T
    VONMEYERRINCK, L
    AUGUSTIN, C
    SCHULZ, M
    KLOSTERHALFEN, H
    SCHMOLDT, A
    ANDROLOGIA, 1990, 22 : 44 - 55